Jessica Coleman, MD
Nephrology · Beaufort, SCNPI 1376785394
Payments from drug & device makers
Across 1,668 payments — averaging $557.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$203K
- Travere Therapeutics, Inc.$186K
- Bayer$116K
- ANI Pharmaceuticals, Inc.$73K
- Akebia Therapeutics Inc$52K
- Vifor Pharma, Inc.$51K
- plus $249K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 321 | $202,613 |
| Travere Therapeutics, Inc. | 351 | $186,141 |
| Bayer | 123 | $115,926 |
| ANI Pharmaceuticals, Inc. | 116 | $73,002 |
| Akebia Therapeutics Inc | 99 | $51,790 |
| Vifor Pharma, Inc. | 107 | $51,263 |
| Amgen(2 entities) | 119 | $49,749 |
| GSK | 40 | $39,435 |
| Otsuka America Pharmaceutical, Inc. | 119 | $39,230 |
| Calliditas Therapeutics US Inc. | 61 | $38,002 |
| Fresenius USA Marketing, Inc. | 61 | $34,483 |
| Novartis | 39 | $22,358 |
| Ardelyx, Inc. | 21 | $18,586 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $1,792 |
| Sanofi | 5 | $1,579 |
| Johnson & Johnson | 2 | $1,315 |
| Mallinckrodt Hospital Products Inc. | 31 | $1,034 |
| Aurinia Pharma U.S., Inc. | 14 | $266 |
| OPKO Pharmaceuticals, LLC | 11 | $191 |
| Nxstage Medical, Inc. | 3 | $179 |
| Mallinckrodt Enterprises LLC | 3 | $159 |
| Corcept Therapeutics | 7 | $147 |
| One Lambda, Inc. | 1 | $128 |
| Chiesi USA, Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| Abbott | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
How this compares
$929,636 in reported general payments places this provider in the 95th percentile of 180 nephrology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Beaufort
- Martin WebbBeaufort$66K
- Barry GorlitskyGreenville$3.1M
- Moustafa MoustafaOrangeburg$3M
- Amy SpragueGeorgetown$1.5M
- Pusadee SuchindaSumter$1.3M
- Asha BaileyColumbia$724K
- Thomas PowellColumbia$704K
- Roberto PisoniCharleston$512K
- Harold SzerlipCharleston$443K
- Howard LiflandColumbia$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.